Implementing the Xpert1MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: Outcomes and lessons learned in 18 countries

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Ardizzoni, Elisa ^a,b   Fajardo, Emmanuel ^b   Saranchuk, Peter ^b   Casenghi, Martina ^b   Page, Anne Laure ^b   Varaine, Francis ^b   Kosack, Cara S ^b   Hepple, Pamela ^b  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; DIAGNOSTIC KIT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MICROSCOPY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; QUALITATIVE RESEARCH; QUESTIONNAIRE; RISK ASSESSMENT; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS RAPID TEST; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DRUG EFFECTS; MICROBIOLOGY; RISK FACTOR; SPUTUM; TREATMENT OUTCOME;

ADULT; CHILD; DIAGNOSTIC TESTS, ROUTINE; DRUG RESISTANCE, BACTERIAL; HUMANS; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; RISK FACTORS; SPUTUM; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84956698324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144656     Document Type: Article

References (28)

1. WHO. Global Tuberculosis report 2014. 2014; Available: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:No+Title#0
2. WHO. Global Tuberculosis report 2014. 2014
3. Boehme C, Nabeta P. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 1005-1015.
4. Hillemann D. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol. 2011; 49: 1202-1205. doi: 10.1128/JCM.02268-10 PMID: 21270230
5. WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF. Policy statement. 2011
6. WHO. The use of the XPERT MTB/RIF assay for the detection of pulmonary and extrapulmonary tuberculosis and rifampicin resistancein adults and children. 2013.
7. WHO. Rapid Implementation of the Xpert MTB/RIF diagnostic test. 2011.
8. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lance. Lancet Publishing Group; 2011; 377: 1495-1505. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgiartid=3085933&tool=pmcentrez&rendertype=abstract
9. Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-Analysis. J Infect. Elsevier Ltd; 2012; 64: 580-8. doi: 10.1016/j.jinf.2012.02.012 PMID: 22381459
10. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, et al. Xpert1MTB/RIFassay for pulmonary tuberculosis and rifampicinresistance in adults. Cochrane Database Syst Rev. 2013
11. Creswell J, Codlin AJ, Andre E, Micek M, Bedru A, Carter EJ, et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect Dis. 2014; 14: 2. doi: 10.1186/1471-2334-14-2 PMID: 24383553
12. WHO. Roadmap to prevent and combat drug-resistant tuberculosis. 2011; Available: http://scholar. google.com/scholar?hl=en&btnG=Search&q=intitle:Roadmap+to+prevent+and+combat+drugresistant+ tuberculosis#0
13. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013. 2013; Available: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle: Consolidated+guideline+on+the+use+of+antiretroviral+drugs+for+treating+and+preventing+HIV +infection#1
14. Cepheid. Xpert MTB/RIF: Product Insert. 2012.
15. FIND. FIND Report: Performance of Xpert MTB/RIF version G4 assay. http://www.stoptb.org/wg/gli/assets/documents/map/findg4cartridge.pdf. 2011
16. Available: http://www.stoptb.org/wg/gli/assets/documents/map/findg4cartridge.pdf
17. Human I, Schopper D. Ethics without borders. PLoS Med. 2009; 6: e1000119. doi: 10.1371/journal. pmed.1000119 PMID: 19636357
18. Stevens W. South Africa's "Reality Check" 1 million Xpert tests [Internet]. p. 205. Available: http://www.stoptb.org/wg/gli/assets/html/GLI5/GLI5thmeetingSAperspectivev7.pdf.
19. Raizada N. Experience with implementation of Xpert MTB/RIF in India [Internet]. Available: http://uwclh. conference2web.com/content/1939?from-view=all&view-Address=events=3&sessions=403
20. Schnippel K, Long L, Stevens WS, Sanne I, Rosen S, Rosen S. Diagnosing Xpert MTB/RIF-negative TB : Impact and cost of alternative algorithms for South Africa. south african Med J. 2013; 103: 101-106. doi: 10.7196/SAMJ.6182
21. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010; 48: 229-37. doi: 10.1128/JCM.01463-09 PMID: 19864480
22. WHO. Proposed reduction of number of smears for the diagnosis of pulmonary TB: background document. Policy statement. 2008; Available: http://medcontent.metapress.com/index/A65RM03P4874243N.pdf
23. Weyer K. Laboratory services in tuberculosis control. Part II: microscopy. World Heal Organ Geneva, Switz. 1998; Available: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Laboratory +services+in+tuberculosis+control.+Part+II.+Microscopy#1
24. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011; 184: 132-40. doi: 10.1164/rccm.201101-0056OC PMID: 21493734
25. Rachow A, Clowes P. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect. 2012 doi: 10.1093/cid/cis190
26. Oberhelman R, Soto-Castellares G, Gilman RH, Caviedes L, Castillo ME, Kolevic L, et al. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis. Elsevier Ltd; 2010; 10: 612-20. doi: 10.1016/S1473-3099(10)70141-9 PMID: 20656559
27. WHO. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement. 2008; Available: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:MOLECULAR+LINE+PROBE+ASSAYS+FOR+RAPID+SCREENING+OF +PATIENTS+AT+RISK+OF+MULTIDRUG-RESISTANT+TUBERCULOSIS+POLICY +STATEMENT#0
28. Cepheid. GeneXpert Dx System: Operator Manual. 2008.